Press Releases

Newsroom
In the News
Press Releases
Resources for Journalists

Press Releases

Share
Share
and/or
510 News Releases found
Ingo Mellinghoff
ASCO 2023: New Research from Memorial Sloan Kettering Cancer Center Identifies Significant Treatment Advancement for Brain Tumors

Ingo K. Mellinghoff, MD, FACP, neuro-oncologist and Chair of the Department of Neurology, presented significant results from a phase III trial in patients with residual or recurrent grade 2 glioma with an IDH1/2 mutation.
MSK Awards & Appointments January 2023
MSK Awards & Appointments May 2023

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.
MSK researchers presenting new research at ASCO 2023, include Carol Aghajanian, MD; Ingo K. Mellinghoff, MD, FACP; and Deb Schrag, MD, MPH
ASCO 2023: Memorial Sloan Kettering Cancer Center Experts to Present Leading Edge Research at the American Society of Clinical Oncology Annual Meeting

Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer during the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, June 2–6 in Chicago.
Marie-Josée and Henry R. Kravis
Memorial Sloan Kettering Cancer Center Announces $40M Gift To Establish The Marie-Josée Kravis Center for Cancer Immunobiology To Advance Immunotherapy Research

The Marie-Josée Kravis Center for Cancer Immunobiology (CCI), made possible by a generous $40 million gift from Henry R. Kravis to honor the visionary leadership of his wife, Marie-Josée Kravis, will establish a strategic research infrastructure that will seamlessly unite MSK scientists and physicians to further accelerate immunotherapy treatments for people with cancer.
Memorial Sloan Kettering Cancer Center Issues Statement on First Quarter 2023 Financial Results

Memorial Sloan Kettering Cancer Center (MSK) issued the following statement regarding its first quarter 2023 financial results today.
Honoring Extraordinary Service in Nursing: Fourth Annual Robbins Family Awards
Honoring Extraordinary Service in Nursing: Fourth Annual Robbins Family Awards

Since 2019, the Robbins Family Foundation has sponsored awards to honor MSK nurses’ extraordinary achievements and contributions to MSK’s mission and core values.
Making Giant Progress: Three Memorial Sloan Kettering Cancer Center Physicians Inducted into Giants of Cancer Care® Class of 2023
Making Giant Progress: Three Memorial Sloan Kettering Cancer Center Physicians Inducted into Giants of Cancer Care® Class of 2023

Memorial Sloan Kettering Cancer Center (MSK) is pleased to announce Eileen M. O’Reilly, MD; Howard I. Scher, MD; and Deb Schrag, MD, MPH, have been elected to the 11th class of Giants of Cancer Care® for their contributions to gastrointestinal cancer care, genitourinary cancer care, and prevention and care delivery respectively.
MSK Awards & Appointments January 2023
MSK Awards & Appointments April 2023

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.
Mike Birbiglia, Zarna Garg, Sarah Silverman, and Hasan Minhaj, performed at Memorial Sloan Kettering Cancer Center’s Comedy vs Cancer, a night of humor and hope to outwit blood cancer on Thursday, April 20, 2023, in New York City. (Photo by Jennifer Pottheiser for Comedy vs Cancer)
Comedy vs Cancer Returns to Lincoln Center, Raising $1.2 Million For Cancer Research at Memorial Sloan Kettering Cancer Center

Comedy vs Cancer, a night of humor and hope to outwit blood cancers, raised $1.2 million for research at MSK. There were a thousand people in the audience in New York City on Thursday, April 20, 2023, at Jazz at Lincoln Center’s Frederick P. Rose Hall.
Dr. Anaeze Offodile Named Chief Strategy Officer at Memorial Sloan Kettering Cancer Center
Dr. Anaeze Offodile Named Chief Strategy Officer at Memorial Sloan Kettering Cancer Center

Dr. Offodile will serve as MSK’s “futurist,” leading strategy efforts and care transformation initiatives at MSK by continuing to develop the core infrastructure, management systems, and processes for enterprise strategy and business development.